Why is TTK Healthcare Ltd. falling/rising?

Short-Term Price Movement and Market Context

TTK Healthcare’s share price rose by ₹6.50, or 0.67%, as of 08:26 PM on 27-Jan, signalling a tentative reversal after four consecutive days of losses. This uptick allowed the stock to outperform its sector by approximately 1% on the day. However, the broader trend remains subdued, with the stock trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day marks. Such positioning indicates that despite the recent bounce, the stock remains under technical pressure.

Investor participation appears to be waning, as evidenced by a 42.1% decline in delivery volume on 23-Jan compared to the five-day average. This reduced trading activity suggests cautious sentiment among shareholders, potentially limiting the strength of any rally.

Long-Term Performance and Valuation Considerations

Over the past year, TTK Healthcare’s stock has declined by 23.28%, markedly underperforming the Sensex, which gained 8.61% during the same period. The stock’s three-year return is also negative at -1.03%, compared to the Sensex’s robust 37.97% gain. Despite this, the company’s five-year return of 81.75% slightly outpaces the Sensex’s 72.66%, indicating some longer-term value creation.

From a valuation standpoint, TTK Healthcare maintains an attractive price-to-book ratio of 1.3 and a return on equity (ROE) of 6.5%. However, the company’s price-to-earnings growth (PEG) ratio stands at a high 8.4, suggesting that the stock may be overvalued relative to its earnings growth prospects. This premium valuation is further underscored by the stock trading above its peers’ historical averages, despite subdued profit growth of just 2.4% over the past year.

Operational and Financial Challenges

Fundamental concerns weigh heavily on the stock’s outlook. Net sales have grown at a modest annual rate of 6.99% over the last five years, while operating profit has expanded at 15.42% annually, reflecting limited growth momentum. The company’s latest half-year results reveal flat performance, with cash and cash equivalents at a low ₹600.89 crores and a debtor turnover ratio of 7.40 times, the lowest recorded. Additionally, non-operating income constitutes a significant 80.43% of profit before tax, raising questions about the sustainability of earnings.

Investor confidence appears tepid, as domestic mutual funds hold a negligible 0.01% stake in the company. Given their capacity for detailed research, this minimal exposure may indicate reservations about the stock’s valuation or business fundamentals.

Market Position and Liquidity

Liquidity remains adequate for trading, with the stock’s average traded value supporting transactions up to ₹0.02 crores based on 2% of the five-day average. Nonetheless, the stock’s recent new 52-week low of ₹955.20 and its underperformance relative to the BSE500 index over multiple time frames highlight ongoing challenges in regaining investor favour.

Conclusion

TTK Healthcare’s recent price rise on 27-Jan represents a short-term recovery following a period of sustained decline. While the stock’s modest gain and outperformance of its sector on the day offer some optimism, the broader picture remains challenging. The company faces slow growth, flat recent results, and valuation concerns that have dampened investor enthusiasm. Trading below all major moving averages and with declining investor participation, the stock’s path to sustained recovery appears uncertain. Investors should weigh these factors carefully against the company’s attractive valuation metrics and liquidity before making decisions.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →